Fate Therapeutics, Inc. (FATE) Revenue Growth
Fate Therapeutics, Inc. (FATE) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | -6.72% |
| 2018-12-31 | 15.44% |
| 2019-12-31 | 125.32% |
| 2020-12-31 | 194.33% |
| 2021-12-31 | 77.66% |
| 2022-12-31 | 72.44% |
| 2023-12-31 | -34.03% |
| 2024-12-31 | -78.55% |
| 2025-12-31 | -51.24% |
How FATE compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| IQV | IQVIA Holdings Inc. | 5.87% |
| TMO | Thermo Fisher Scientific Inc | 3.91% |
| GILD | Gilead Sciences Inc. | 2.40% |
| ILMN | Illumina Inc. | -0.66% |
| RMTI | Rockwell Medical Inc. | -31.76% |
These are five companies in the same sector as FATE with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Fate Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("FATE", 2025, "")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | FATE | $2.14 | -1.65% | 0.04M |
| 3 | ||||
| 4 | ||||
| 5 |